Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
22 Maggio 2024 - 10:07AM
Capital Increase in Bavarian Nordic A/S as a Result of Employee
Warrant Exercise
COPENHAGEN, Denmark, May 22, 2024 –
Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's
share capital has been increased by nominally DKK 187,020 as a
consequence of employees’ exercise of warrants.
The capital increase was effected without any
pre-emption rights for the existing shareholders of the Company or
others. A total of 18,702 new shares were subscribed for in cash at
DKK 146.60 per share of nominally DKK 10. The total proceeds to
Bavarian Nordic A/S from the capital increase amounts to DKK 2.7
million.
The new shares, which will rank pari passu in
all respects with existing Bavarian Nordic shares, will be admitted
to trading and official listing on Nasdaq Copenhagen as soon as
possible.
After the capital increase, the total nominal
value of Bavarian Nordic A/S' share capital is DKK 781,165,360,
which is made up of 78,116,536 shares of a nominal value of DKK 10
each, corresponding to 78,116,536 votes.
The revised Articles of Association will be
published shortly on the Company's website.
The content of this announcement does not affect
the Company’s expectations for the financial results for 2024.
About Bavarian NordicBavarian Nordic is a
fully integrated vaccine company with a mission to protect and save
lives through innovative vaccines. We are a global leader in
smallpox and mpox vaccines, supplied to governments to enhance
public health preparedness and have a strong portfolio of vaccines
for travelers and endemic diseases. For more information visit
www.bavarian-nordic.com.
Forward-looking statements This
announcement includes forward-looking statements that involve
risks, uncertainties and other factors, many of which are outside
of our control, that could cause actual results to differ
materially from the results discussed in the forward-looking
statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance
and/or other information that is not historical information. All
such forward-looking statements are expressly qualified by these
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. We undertake no
obligation to publicly update or revise forward-looking statements
to reflect subsequent events or circumstances after the date made,
except as required by law.
ContactsEurope: Rolf Sass Sørensen, Vice
President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61
77 47 44 US: Graham Morrell, graham@paddockcircle.com, Tel: +1 781
686 9600
Company Announcement no. 16 / 2024
Grafico Azioni Bavarian Nordic AS (TG:BV3)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Bavarian Nordic AS (TG:BV3)
Storico
Da Nov 2023 a Nov 2024
